Testing version — LOERadar is in active testing. Features and data may change.
MONOPRIL (FOSINOPRIL SODIUM) | LOERadar
MONOPRIL
NDA
FOSINOPRIL SODIUM | N019915 | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE
3 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (3)
Sort:
#002 — 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▴
TABLET;ORAL | Approved: May 16, 1991
No patent or exclusivity listings for this strength.
#003 — 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▾
TABLET;ORAL | Approved: May 16, 1991
#004 — 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**